Heart Disease Trial, Recruiting NCT06216847 Sponsor: Shenyang Northern Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06216847
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been admitted to hospital with confirmed or suspected coronary heart disease (a condition affecting the blood vessels of the heart), and who also have at least one of the following: a history of a procedure to open blocked heart arteries (such as a stent or bypass surgery); a previous heart attack; a previous heart scan showing a significant blockage in a major heart artery; chest pain with a high likelihood of being caused by heart disease; blood test results showing the heart muscle is not getting enough blood; or a special heart CT scan showing a blockage of 30% or more in a major heart artery
  • People who have had at least one imaging test of the heart arteries (such as a CT scan, an ultrasound probe inside the artery, or a light-based camera inside the artery) AND at least one test measuring blood flow through the heart arteries
  • People who have given written agreement to take part in the trial

Who may not be able to join:

  • People with a history of mental illness, or drug or alcohol misuse, or anyone who is unable to attend follow-up visits for any reason
  • People whose life expectancy is less than one year
  • People who are pregnant or who plan to become pregnant within the next year
  • People who are currently taking part in another clinical trial
  • People considered unsuitable for the trial for other reasons, as decided by the doctor running the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yaling Han, MD, The General Hospital of Northern Theater Command

Phone: +86-24-28897309

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shenyang Northern Hospital
Registry
ClinicalTrials.gov
Start date
21 February 2024
Est. completion
31 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Ischemic events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov